CHICAGO — An AI model using electronic health record data helped researchers narrow down who should be screened for primary aldosteronism, according to a poster presented at ENDO 2026.“With primary aldosteronism, the information and treatments we need already exist — the challenge has been putting them into practice,” Frank Lee, MD, trainee at Mayo Clinic in Rochester,